Is Big Pharma About To Win? Goldman Sachs Weighs In On 340B And Medicaid Shifts
Goldman Sachs analyst Salveen Richter highlights potential benefits for biopharma from 340B reforms, while Medicaid cuts ...
Heartland16d
States Differ in Responses to 340B Program Abuse
Widespread and longstanding abuse of the 340B federal drug program has prompted state lawmakers to take action.
STAT13h
Pharmalittle: We’re reading about FDA OK for Vertex non-opioid pain drug, vaccine advisory committee, and more
Vertex Pharmaceuticals won approval from the U.S. Food and Drug Administration for a non-opioid pain drug, clearing the way for the rollout of a product that has simultaneously sparked high hopes and ...
A GOP lawmaker wants to protect drug discounts in Utah. A dark money group is fighting his bill.
A dark money group is attacking a Utah GOP senator's bill meant to protect access to a federal program requiring drug ...
nptelegraph10h
Next week's Unicam hearings include Medicaid, youth social media use
Unicameral committees start taking testimony at 1:30 p.m. on bills scheduled that day. Livestreams of hearings and texts of ...
The Hayride2d
LUNSFORD: The Court Fight Between Louisiana And Big Pharma
On January 20, a new administration began addressing our nation’s pressing problems, including health care costs. Drug costs ...
aha.org3d
White House pauses federal grants, other programs implicated by executive orders; OMB says Medicare and Medicaid not affected by pause
The White House Office of Management and Budget late Jan. 27 issued a memo directing federal agencies to temporarily pause federal grants, loans and other financial assistance programs implicated by ...